Go Pro

43,063 Shares in Revvity Inc. $RVTY Acquired by Tocqueville Asset Management L.P.

Revvity logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Tocqueville Asset Management acquired 43,063 shares of Revvity worth approximately $4.79 million in the second quarter. Institutional investors collectively own 86.65% of the company.
  • Revvity reported quarterly EPS of $1.41, beating estimates of $1.21, while revenue reached $729.69 million versus expectations of $702.96 million. However, revenue declined 1.3% year over year.
  • Analysts maintain a consensus “Hold” rating with an average price target of $108.36, below the stock’s reported price of $124.02. Revvity also declared a quarterly dividend of $0.07 per share, yielding 0.2% annually.
  • MarketBeat previews the top five stocks to own by September 1st.

Tocqueville Asset Management L.P. bought a new position in Revvity Inc. (NYSE:RVTY - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 43,063 shares of the company's stock, valued at approximately $4,791,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. New Mexico Educational Retirement Board increased its holdings in Revvity by 1.9% in the 4th quarter. New Mexico Educational Retirement Board now owns 5,416 shares of the company's stock valued at $524,000 after acquiring an additional 100 shares during the last quarter. Allworth Financial LP boosted its holdings in shares of Revvity by 8.9% during the 4th quarter. Allworth Financial LP now owns 1,275 shares of the company's stock valued at $123,000 after purchasing an additional 104 shares during the last quarter. EverSource Wealth Advisors LLC boosted its holdings in shares of Revvity by 17.0% during the 1st quarter. EverSource Wealth Advisors LLC now owns 749 shares of the company's stock valued at $66,000 after purchasing an additional 109 shares during the last quarter. HighTower Advisors LLC boosted its holdings in shares of Revvity by 2.6% during the 4th quarter. HighTower Advisors LLC now owns 5,141 shares of the company's stock valued at $497,000 after purchasing an additional 129 shares during the last quarter. Finally, Cary Street Partners Financial LLC grew its position in shares of Revvity by 1.6% during the fourth quarter. Cary Street Partners Financial LLC now owns 8,941 shares of the company's stock valued at $865,000 after purchasing an additional 141 shares in the last quarter. Institutional investors own 86.65% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the company. Weiss Ratings raised Revvity from a "sell (d+)" rating to a "hold (c-)" rating in a report on Thursday, July 30th. Robert W. Baird set a $117.00 price target on Revvity in a report on Wednesday, May 6th. TD Cowen reaffirmed a "buy" rating on shares of Revvity in a research note on Wednesday, July 15th. Sanford C. Bernstein started coverage on Revvity in a report on Friday, June 26th. They set a "market perform" rating and a $115.00 price objective on the stock. Finally, JPMorgan Chase & Co. lowered their target price on Revvity from $96.00 to $90.00 and set a "neutral" rating for the company in a research report on Wednesday, May 6th. Three equities research analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $108.36.

Check Out Our Latest Analysis on RVTY

Revvity Stock Performance

NYSE RVTY opened at $124.02 on Friday. The business's 50 day moving average price is $110.94 and its 200-day moving average price is $100.20. Revvity Inc. has a fifty-two week low of $81.22 and a fifty-two week high of $124.49. The company has a market cap of $13.84 billion, a P/E ratio of 59.06, a P/E/G ratio of 2.18 and a beta of 1.07. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.50 and a current ratio of 1.80.

Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $1.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.21 by $0.20. The company had revenue of $729.69 million during the quarter, compared to the consensus estimate of $702.96 million. Revvity had a return on equity of 8.34% and a net margin of 8.16%.Revvity's revenue was down 1.3% on a year-over-year basis. During the same period last year, the company earned $1.18 earnings per share. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. Sell-side analysts predict that Revvity Inc. will post 5.36 earnings per share for the current year.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be issued a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.2%. The ex-dividend date is Friday, October 23rd. Revvity's dividend payout ratio (DPR) is 13.33%.

Revvity Profile

(Free Report)

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.

Recommended Stories

Institutional Ownership by Quarter for Revvity (NYSE:RVTY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Revvity Right Now?

Before you consider Revvity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Revvity wasn't on the list.

While Revvity currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines